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The functional impact of several long intergenic non-coding RNAs (lincRNAs) has been characterized in previous studies. 
However, it is difficult to identify lincRNAs on a large-scale and to ascertain their functions or predict their structures in labor-
atory experiments because of the diversity, lack of knowledge and specificity of expression of lincRNAs. Furthermore, alt-
hough there are a few well-characterized examples of lincRNAs associated with cancers, these are just the tip of the iceberg 
owing to the complexity of cancer. Here, by combining RNA-Seq data from several kinds of human cell lines with chroma-
tin-state maps and human expressed sequence tags, we successfully identified more than 3000 human lincRNAs, most of 
which were new ones. Subsequently, we predicted the functions of 105 lincRNAs based on a coding-non-coding gene 
co-expression network. Finally, we propose a genetic mediator and key regulator model to unveil the subtle relationships be-
tween lincRNAs and lung cancer. Twelve lincRNAs may be principal players in lung tumorigenesis. The present study com-
bines large-scale identification and functional prediction of human lincRNAs, and is a pioneering work in characterizing can-
cer-associated lincRNAs by bioinformatics.  
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Long intergenic non-coding RNAs (lincRNAs), a kind of 
non-coding RNA that were long (>200 nt) and located in the 
intergenic region of genome, have been paid great attention 
recently for their regulatory role in many biological pro-
cesses. Several research teams have already identified a few 
thousand relatively reliable lincRNAs from mammalian 
genomes, such as those of human and mouse [1–5]. These 
lincRNAs had been reported to localize to specific subcel-
lular compartments [6], be involved in numerous regulatory 
process, exhibit cell type-specific expression [7] and be 
associated with various diseases. Notably, several lincRNAs 
have been found to be oncogenic or tumor-suppressor genes 
and to play important roles in key cancer pathways at tran-
scriptional, post-transcriptional and epigenetic levels [8,9]. 
However, owing to the complexity of lincRNAs, studying 
the functions of lincRNAs is difficult. How many lincRNAs 
are there, what functions do they have, and which are asso-
ciated with disease or cancer? All these questions remain 
unanswered.  
Current studies of lincRNAs fall into three main catego-
ries. The first category includes studies aimed at identifying 
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lincRNAs. Thousands of lincRNAs have been collected into 
several databases, such as H-inv [10], GENCODE [11], 
RefSeq [12] and FANTOM [13]. A few studies have identi-
fied some relatively reliable lincRNA regions or transcripts 
based on previous experimental data. For instance, by 
searching for the chromatin signature of actively transcribed 
genes [14,15], more than 1600 and 3300 regions containing 
lincRNAs were identified in the mouse and human genomes, 
respectively. With the development of sequencing technol-
ogy, lincRNAs have been identified from RNA-seq data. 
For example, Guttman et al. [16] identified more than a 
thousand lincRNAs using software named Scripture, which 
can reconstruct full-length gene structures from RNA-Seq 
data. Recently, over 8000 human lincRNAs were assembled 
from RNA-Seq data across 24 tissues and cell types [17]. 
Numerous lincRNAs may still be uncovered; however, it is 
still a challenge to get the complete catalog of the lincRNAs 
in mammalian genomes.  
The second category of studies includes those aimed at 
performing a functional analysis of lincRNAs. Unlike mi-
croRNAs or proteins, the functions of lincRNAs cannot be 
inferred from their sequences or structure characteristics 
owing to the diversity of lincRNAs [8]. In addition, func-
tional analysis of lincRNAs is also hampered by the lack of 
collateral information such as large scale molecular interac-
tion data and expression profiles. Although a few lincRNAs, 
such as HOTAIR [18], AIR [19], Kcnq1ot1 [20] and lin-
cRNA-p21 [21], have been functionally characterized ex-
perimentally, and computational workflows for lincRNA 
functional annotation have been designed [22], the functions 
of a large number of lincRNAs remain unknown.  
The third category of studies on lincRNAs includes those 
exploring the links between lincRNAs and diseases or can-
cer. It has been reported that lincRNAs show differences in 
expression profiles between normal and tumor samples, and 
that they have a major role in the development and progres-
sion of cancer. For example, in primary breast tumors and 
metastases, the lincRNA HOTAIR is highly expressed and 
interacts with polycomb repressive complex 2 (PRC2). This 
results in an altered pattern of H3K27 methylation of target 
genes and, thus, an increase in invasiveness and metastasis, 
whereas the depletion of HOTAIR inhibited cancer inva-
siveness [23]. Other cancer-associated lincRNAs such as 
lincRNA-p21, ANRIL and MALAT-1 also have similar 
roles [24]. However, to date, one study has characterized the 
association between lincRNAs and cancer [25], and the 
mechanisms by which lincRNAs affect tumor initiation 
and/or progression remain poorly understood. To further 
understand lincRNAs, it is necessary to study human lin-
cRNAs from all three angles systematically. 
In the present study, by combining RNA-Seq reads from 
several kinds of human cell lines with chromatin-state maps 
and human expressed sequence tags (ESTs), more than 
3000 human lincRNAs were successfully identified, almost 
all of them new ones. Next, we re-annotated the probes of 
Human Genome U133 Plus 2.0 Array to obtain expression 
profiles for the newly identified lincRNAs. Then a cod-
ing-non-coding gene co-expression network was construct-
ed to determine the functions of the lincRNAs. Finally, we 
proposed a genetic mediator and key regulator model to 
explore cancer-associated lincRNAs and their putative 
mechanisms. As a result, we identified three lincRNAs act-
ing as genetic mediators and twelve acting as key regulators 
that may play key roles in several important cancer path-
ways such as the cell cycle and immune processes in lung 
tumorigenesis. The evidence gathered from this work pro-
vides a new approach for computational and systematical 
analyses of lincRNAs, as well as clues to the functions of 
lincRNAs and possible roles in cancer. 
1  Materials and methods 
1.1  Data downloading and processing 
Nine human paired-end RNA-Seq data sets spanning six 
cell types (accession numbers shown in Table S1) were 
downloaded from the Sequence Read Archive (SRA) data-
base in NCBI (http://www.ncbi.nlm.nih.gov/sra) in Septem-
ber 2010. These RNA-Seq reads, in FASTQ format, consist 
of one or more runs, each of which has two files for inde-
pendent left and right reads. 
The human reference genome sequence (Hg18) and all 
RefSeq coding and noncoding genes were downloaded from 
the University of California Santa Cruz (UCSC) Genome 
Browser. H-inv transcripts were obtained from UCSC Table 
Browser. Human ESTs located within protein-coding genes 
and lincRNA regions as well as their positional data were 
obtained from the UCSC Table Browser.  
We obtained the list of all human lincRNA regions in the 
human genome (Hg18) along with mouse lincRNA regions 
as determined by Guttman et al. [16] in the mouse genome 
(MM8), and used the liftOver (http://genome.ucsc.edu/ 
cgi-bin/hgLiftOver) tool to identify their orthologous loca-
tions in the human genome (Hg18).  
Microarray data sets were downloaded from the Gene 
Expression Omnibus (GEO) database. Accession numbers 
of data sets used are GSE7216, GSE12161, GSE6241, 
GSE8884, GSE10313, and GSE10021 (Table S2). 
1.2  Identification of lincRNAs 
First, experiment reads were aligned to the human reference 
genome (Hg18) using the TopHat aligner. Then, Scripture 
was run separately according to the walkthrough described on 
the website (http://www.broadinstitute.org/software/scripture/ 
Walkthrough_example). For each experiment, the final 
Scripture results included BED files containing all recon-
structed transcripts and the expression levels of these tran-
scripts, as well as DOT files containing a transcript graph 
constructed within Scripture. Second, we compiled the re-
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sults of the nine experiments into a single file containing 
information about all of the transcripts reconstructed, using 
the findpeaks method (setting parameters “-dist_type 3 
-subpeaks 0.2 -minimum 1 -trim 0.65”). Third, we sub-
tracted all transcripts mapping to exons, introns and the an-
tisense transcripts overlapping the protein-coding genes and 
eliminated those less than 200 bp in length and within 1 kb 
of protein-coding genes. 
To construct EST-origin transcripts, we extracted all 
ESTs located within either protein-coding genes or lin-
cRNA regions. Next, within each gene unit, we used the 
findpeaks method to identify EST peaks using the parame-
ters “-dist_type 3 -subpeaks 0.2 -minimum 5 -trim 0.25”. 
After trimming and filtering, we join the peaks by turns in 
the same gene location according to the orientation of ESTs. 
We combined Scripture-origin and EST-origin noncod-
ing transcripts. To measure coding potential capacity, all 
noncoding transcripts and protein-coding gene sequences 
were submitted in FASTA format to CNCI software (in 
house) and the CPC web server (http://cpc.cbi.pku.edu.cn/). 
Based on the CNCI and CPC score distribution of coding 
and noncoding genes, we removed noncoding genes with a 
CNCI score above a threshold of 10 and those with a CPC 
score above 0. To estimate the evolutionary constraints 
among mammalian sequences we constructed the cumula-
tive distribution of PhastCons scores for introns, RefSeq 
coding genes and our lincRNAs. To detect the gene transcrip-
tional signature, we detected the H3K4me3 and H3K36me3 
peaks generated by the Broad/MGH ENCODE group in 
gene promoter and gene body regions, respectively.  
1.3  MSD value 
Mean similarity degree (MSD) values were used to evaluate 
the strength of the sequence similarity between two tran-
scripts, defined as MSD=(Loverlap/LT1+Loverlap/LT2)/2, where 
LT1 and LT2 are the length of two transcripts, Loverlap is the 
length of the overlapping regions between them. 
1.4  Findpeaks method 
Findpeaks is a piece of java software developed by Fejes, 
which can identify areas of fragment enrichment. It is 
available at “http://www.bcgsc.ca/platform/bioinfo/software/ 
findpeaks”. First, the bed file of all fragments was separated 
by chromosome, and sorted by read position. Next, we set 
up the findpeaks parameters such as subpeaks and trim at 
the appropriate thresholds, and ran Findpeaks. 
1.5  Probe re-annotation 
We used probe re-annotation pipeline as previously de-
scribed [22]. Briefly, probe sequences for the Affymetrix 
Human Genome U133 Plus 2.0 Array downloaded from the 
Affymetrix website were aligned to our lincRNA sequences 
and to the RefSeq coding transcript sequences, respectively, 
using BLASTn. Only perfectly matched probes and tran-
scripts were maintained, resulting in two sets of probes tar-
geting protein-coding and non-coding transcripts. We re-
moved probes in the non-coding probe set that perfectly 
matched RefSeq coding sequences. Next, we used the En-
trez GeneID as an identifier of coding genes, and mapped 
the protein-coding probes from the transcription level to the 
gene level. Finally, we removed the probes that matched 
more than two genes or non-coding transcripts and selected 
the genes and transcripts that have at least three probes. A 
new CDF package (called re-annotated hgu133plus2) cov-
ering the re-annotated probe-gene relationships was created 
using R package. 
1.6  Comparison of gene expression as measured by 
RNA-Seq and re-annotated Human Genome U133 Plus 
2.0 Array 
RNA­Seq data were used to measure the expression levels 
of transcripts in conjunction with Scripture software, which 
computed reads per kilobase of exon model per million 
mapped reads (RPKM). Preprocessing of microarray data 
was done using R Bioconductor software and consisted of 
Robust Multichip Average (RMA) background correction, 
constant normalization and expression summarization as 
described by Liao et al. [22]. Expression intensity was log2-     
transformed. For each cell line, Spearman correlation coef-
ficients for the same genes in the two data sets were calcu-
lated. For each non-coding gene, the correlations among the 
expression levels across six cell lines in the two data sets 
were also calculated. As a control, non-coding genes were 
randomly paired and Spearman correlation coefficients were 
computed. The control step was repeated 1000 times. 
1.7  Gene correlation and construction of the co-   
expression network 
Thirty-one data sets were used to construct the coding-    
non-coding gene co-expression network. For each data set, 
the data processing was similar to the workflow previously 
described [22]. Briefly, genes with expressional variance 
ranked in the top 75th percentile of each data set were re-
tained. Second, a set of Pearson correlation coefficient (Pcc) 
P-values for each gene pair was estimated using Fisher’s 
asymptotic test and adjusted using the Bonferroni multiple 
test correction. Only gene pairs with a P-value 0.01 and 
with a Pcc value ranked in the top or bottom 0.5 percentile 
for each gene were regarded as co-expressed in the given 
data set. Third, each gene pair was assigned a score accord-
ing to the number of data sets in which the gene pair was 
co-expressed in the same ‘direction’ (i.e., positively or neg-
atively). We constructed several networks using different 
thresholds (the number of data sets) and measured the topo-
logical properties of the resulting networks. All of the above 
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processes, including determining the clustering coefficient, 
gamma, and scale-free topology criteria, were implemented 
in R software.  
1.8  Random networks 
Random networks were constructed as previously described 
[22]. Briefly, random networks consisted of the same genes 
as in the observed networks and have the same topological 
properties as observed networks. To do this, a gene in the 
random network had the same number of connections as in 
the observed network, but its links to other genes were ran-
dom instead of being based on co-expression patterns. 
1.9  Enrichment analysis 
Enrichment analysis of Gene Ontology Biological Processes 
as well as KEGG pathways were performed using the 
g:profiler web server with the default parameters. 
1.10  Genetic mediators of cancer 
The reverse-engineered networks used the mode-of-action 
by network identification (MNI) algorithm, which involved 
two phases as described previously. In phase one, we used a 
total of 1037 microarray expression profiles spanning sev-
eral different cancer types as a training set to reverse engi-
neer a coding-noncoding gene regulatory network. In phase 
two, we used the expression profiles of lung cancers and 
normal samples as a test set and the network as a filter to 
determine the genes affected by these conditions. The MNI 
algorithm software was downloaded from the website 
“http://gardnerlab.bu.edu”. The parameters used with the 
MNI algorithm software are as follows: the threshold for 
significant external influence (thP) was set to 0.25; the frac-
tion of genes to be kept (Kfrac) was set to 0.33; and the 
number of rounds (NROUNDS) was set to 3. 
1.11  The cancer gene set map 
We obtained gene expression profiles for five data sets in-
cluding 546 arrays spanning four cancer types and normal-
ized the expression of each gene in every data set separately. 
First, the expression value of each gene g was log2-trans-    
formed (truncating to an expression value of 10 any below 
that value). Second, we normalized the (log2-transformed) 
expression value of gene g in each array relative to its av-
erage expression in all the arrays in the same data set, by 
subtracting its average expression value in that data set. We 
then extracted coding and non-coding gene centered gene 
set from our co-expression network, which consists of a 
central gene that have our functional annotations and coding 
genes that connect directly to it. By creating a gene set map, 
we used Genomica software, which can characterize an ex-
pression dataset on the basis of gene sets and experiment 
sets that significantly change within it. Genomica download 
and workflow are available at http://genomica.weizmann. 
ac.il/Tutorial/create_module_map.html.  
2  Results 
2.1  Integrated method to identify human lincRNAs 
In the method based on the RNA-Seq data, nine human 
RNA-Seq experimental data sets spanning six cell types 
downloaded from ENCODE project [26] were used to con-
struct transcripts using Scripture [16] (Table S1). Then, nine 
sets of transcripts were combined and 19640 non-overlapping, 
multi-exonic transcripts called as scripture-origin transcripts 
were obtained, among which 16972 corresponded to RefSeq 
protein-coding genes (Figure S1). The MSD value, which 
was defined to evaluate the strength of sequence similarity 
of two transcripts (Materials and methods), was high be-
tween these transcripts and corresponding RefSeq coding 
genes (Figure 1A), indicating that the transcripts construct-
ed by Scripture were of good quality. Then, all scripture-     
origin transcripts that were mapped to exons, introns and the 
antisense transcripts of protein-coding genes were subtract-
ed. In addition, transcripts less than 200 nt in length and 
those within 1 kb of the protein-coding genes were elimi-
nated to avoid promoter and 3′-associated transcripts. The 
pipeline led to 1746 putative lincRNAs with an average 
length of 1.4 kb, and with 3.9 exons of 355 bp on average, 
among which 449 overlapped with the 3000 distinct lin-
cRNA loci that were previously identified based on the 
K4-K36 regions described by Khalil et al. [15].  
Then, we constructed new lincRNA gene structures using 
a method based on expressed sequence tags (ESTs), which 
were usually used to discover new transcript models (Figure 
S1). All human ESTs located in both protein-coding gene 
and lincRNA regions were used to find EST-peaks in con-
junction with FindPeaks software [27]. Using an appropriate 
threshold, the left EST-peaks were linked to the corre-
sponding genes. Finally, 18959 transcripts corresponding to 
18712 coding genes and 1995 lincRNA regions were con-
structed and named as EST-origin transcripts. The quality of 
these transcripts was also high, with high MSD values for 
EST-origin transcripts and their corresponding RefSeq pro-
tein-coding transcripts (Figure 1A). On average, the 1995 
lincRNA regions were 1.6 kb long, and had 4.5 exons of 
356 bp. In addition, 317 overlapped with 341 scripture-     
origin lincRNAs in the genome region.  
Combining the 1746 scripture-origin lincRNAs with 
1995 EST-origin lincRNAs, 3528 putative lincRNAs in 
human genome were identified in total, among which 563 
had been annotated as RefSeq noncoding RNAs. Evaluating 
the coding potential of each unannotated lincRNA using 
Coding-Non-Coding Index (CNCI) software (in house) and 
a Coding Potential Calculator [28], we found that almost  
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Figure 1  Integrated method to identify human lincRNAs. A, Distribution of mean similarity degree (MSD) values between scripture-origin coding genes 
and RefSeq coding genes (black), EST-origin coding genes and RefSeq coding genes (red), our identified lincRNA genes and RefSeq non-coding genes 
(green), our identified lincRNA genes and Human Body Map (HBM) lincRNA genes (blue), and our identified lincRNA genes and H-inv non-coding genes 
(cyan). B, Conservation of the genomic transcript sequences for lincRNAs, protein-coding genes and introns. 
90% of them were predicted as non-protein-coding genes. 
After eliminating those transcripts that were predicted as 
coding genes, 3215 putative lincRNAs were left; on average, 
these were 1.5 kb long, with 4.1 exons of 358 bp (File S1). 
Among the 3215 lincRNAs, 17% overlapped with RefSeq 
noncoding genes, 27% overlapped with H-inv transcripts 
[10], while 12% overlapped with Human Body Map lin-
cRNAs [17]. MSD values for comparisons between our 
identified lincRNAs and the above three types were high 
(Figure 1A), indicating the good quality of these lincRNAs. 
Furthermore, we compared our lincRNAs catalog with 
transcripts of GENCODE V12 identified by the ENCODE 
project [29], which has just published 30 papers including a 
few that extensively characterize lincRNAs, and found  
that 47% (1502/3215) of our lincRNAs overlapped with 
GENCODE transcripts in terms of genomic location. The 
sequence conservation of the lincRNAs was lower than that 
of protein-coding genes but higher than that of intron re-
gions (Figure 1B). Moreover, chromatin signature analysis 
revealed that >60% of these lincRNAs had both H3K4me3 
peaks in the promoter region and H3K36me3 peaks in the 
gene body, implying that lincRNAs have a similar tran-
scriptional signature to protein-coding genes [1,2]. Alto-
gether, using RNA-Seq and EST data sets we identified, in 
total, 3215 human lincRNAs, among which nearly 80% 
were novel.  
2.2  Expression profiles of lincRNAs 
To analyze the expression of lincRNAs, we used our previ-
ously well-established computational workflow to re-annotate 
the probes of Human Genome U133 Plus 2.0 Array [22]. As 
a result, 297510 and 5731 of 604258 probes were mapped 
to 16883 protein-coding RNAs and 492 lincRNAs, respec-
tively, and were used to assemble a new chip-description 
file. To evaluate the accuracy of the re-annotated array, we 
compared the expression levels of the mRNAs and lin-
cRNAs detected based on RNA­Seq data with those detect-
ed by the re-annotated Human Genome U133 Plus 2.0 Ar-
ray. The results showed that the expression levels of both 
mRNAs and lincRNAs from the two independent datasets 
had a significantly high level of correlation (P-value of the 
KS test were less than 1010) (Figure S2A). Furthermore, the 
two independent datasets detected several of the same cell 
type-specific lincRNAs (Figure S2B). 
2.3  Predicting lincRNA gene functions using co-expre-     
ssion networks 
Next, a coding-non-coding gene co-expression network was 
constructed and used to determine lincRNA functions by the 
methods described previously [22]. Thirty-one microarray 
datasets involving a number of biochemical and biophysical 
conditions, various tissue resources, and diverse biological 
processes from GEO were used to construct the co-expre-   
ssion network (Table S2). The last co-expression network 
was composed of the gene pairs that were co-expressed in at 
least a certain cutoff of microarray datasets. To obtain a 
co-expression network with high quality, we evaluated the 
topological properties of a series of networks obtained by 
different cutoffs (edges between two genes were included in 
the network only if the two genes were co-expressed in the 
same direction in more than a given number of datasets) 
(Table S3). GO term overlap analysis showed that the higher 
the cutoff, the more similar were the annotated functions of 
neighboring genes in the network (Table S3). Based on the 
topologies of the networks, we focused on the co-expression 
network that was constructed with a cutoff of 5 to obtain 
accurate topological and biological properties. The resulting 
network included 256 lincRNA genes and 10802 coding 
genes, with 48946 coding-coding edges, 2721 coding-     
noncoding edges and 79 noncoding-noncoding edges (Table 
S3). 
The ‘two-color’ co-expression network had a scale-free 
 Sun L, et al.   Sci China Life Sci   April (2013) Vol.56 No.4 329 
topology, which satisfies the required characteristics of bi-
ological networks [30] (Table S3). For example, our net-
work comprised many genes with relatively few connec-
tions (mean=9, median=4), but a few genes, also called as 
hubs, had large number of connections and could influence 
the expression of many other genes. The gene pairs in the 
co-expression network shared many Gene Ontology (GO) 
annotations (P<1016), more than did those in the random 
network (Table S3). Of the 48946 coding-coding gene pairs, 
32740 pairs had identical GO annotations, among which 
6536 (20%) had the same GO annotations, while only 5% in 
the random network did. These results suggested that our 
co-expression network had appropriate topological and bio-
logical properties. 
To obtain the functional characteristics of lincRNAs, two 
different methods including gene-centered and co-expressed 
module sub-networks [22,31] were used to predict functions. 
First, we parsed the co-expression network into 4688 sub-      
networks, each of which consisted of a central gene and its 
directly connected genes. Among them, 114 were lincRNA-      
centered while 4574 were coding gene-centered subnet-
works. Then, we calculated the enriched GO terms for each 
subnetwork and found that 3054 (65%) (2954 coding 
gene-centered and 100 lincRNA-centered subnetworks) had 
at least one significantly enriched GO term. Of the 2954 
central coding genes, 1112 (38%) had the same GO terms as 
previously annotated; by contrast, only 188/2761 (7%) in 
the random (P<1016) (2716 coding gene-centered subnet-
works were found in random network). These results 
demonstrated that the predicted functions of 100 central 
lincRNAs were relatively reliable. Second, we used the 
MCL algorithm to parse the network into 2872 modules 
with five or more genes, of which 209 modules had at least 
one enriched GO term; 21 of these were composed of both 
coding and noncoding genes, involving 23 lincRNAs, 
among which 18 had also been predicted by the first method 
and 13 had the same predicted functions. Altogether, 105 
lincRNAs’ functions were predicted using the two above 
methods (File S2). For example, TUG1 (named Both_114 in 
our catalog of lincRNA genes) may serve as a downstream 
transcriptional repressor in the p53 pathway to repress 
cell-cycle progression in response to DNA damage [15]. To 
further validate the predicted functions of lincRNAs, we 
analyzed the expression characters of lincRNAs through the 
re-annotated expression profiles of three cell lines treated 
with a cyclin-dependent kinase (CDK) inhibitor. In total, 
1254 coding genes and 39 lincRNA genes were differen-
tially expressed in a dose-responsive manner to the CDK 
inhibitor, and these were shared by all three cell lines (Fig-
ure S3A and B). GO biological process enrichment analysis 
(Figure S3C) revealed that the functions of 1254 coding 
genes were significantly enriched for “cell cycle” and “re-
sponse to DNA damage stimulus” pathways, consistent with 
evidence that CDK inhibitors cause dysregulation of the cell 
cycle [32]. Among the 39 differentially expressed lincRNAs, 
16 had functional annotation and most of them have regula-
tory functions. Another lincRNA named Est_835, whose 
function was predicted as cell cycle regulation, was differ-
ently expressed following CDK inhibitor treatment, sug-
gesting that it may be involved in the cell cycle pathway 
(File S2). 
2.4  Predicting the roles of lincRNA genes implicated in 
cancer 
To study the relationship between lincRNAs and cancer, we 
proposed a genetic mediator and key regulator model, 
which can identify genes directly affected by cancer or 
which play key roles in tumorigenesis. The description of 
the model was as follows. We considered that cancer was 
caused by the dysregulation of the genes involved in a can-
cer-related network (CRN), which consisted of a variety of 
connections such as protein-protein interactions and regula-
tory interactions, and which may be responsible for tumor 
occurrence, growth and metastasis. Although hundreds to 
thousands of genes show different expression levels in can-
cer compared with normal samples, only two types of genes 
in the CRN are important for tumorigenesis. One is genes 
whose different expression between tumor and normal sam-
ples is the main reason for dysregulation of cellular path-
ways. These genes are usually directly affected by cancer 
and located in the top layer of the CRN, and are called ge-
netic mediators of cancer (Figure 2A). Another type is hubs 
of the CRN, whose alteration leads to the dysregulation of 
their numerous regulated genes and which act as key regu-
lators during cancer development (Figure 2A).  
We applied the genetic mediator and key regulator model 
to lung cancer and found several genetic mediators. First, 
we identified genes, including both coding and lincRNAs, 
that were differentially expressed in cancer, and further ob-
tained genetic mediators via reverse-engineered gene regu-
latory networks, which had been verified as effective in 
prostate cancer [33,34]. The reverse-engineered network is 
a directed graph that reflects the contribution of each gene 
to the others, and in which the edge represents how the ac-
tivity of one gene (genetic mediator) influences the tran-
scription of another gene. Using this method, we obtained 
100 top genetic mediators including three lincRNAs specific 
to lung cancer (Table S4, Figure S4). GO enrichment analy-
sis showed that the functions of these cancer-specific ge-
netic mediators were mainly cell proliferation and signal 
transduction (Figure 2B). This result was consistent with the 
previous conclusion that most of the mutated genes in lung 
adenocarcinoma were involved in several important signal-
ing pathways, such as cell proliferation, cell death and the 
cell cycle [35]. To further validate our predictions, we col-
lected 2897 lung cancer-related genes, which were extracted 
manually from the literature or which showed occurrence of 
somatic mutations in lung cancer, and found that 42 of 97 
coding genetic mediators had been experimentally validated  
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Figure 2  LincRNA genes implicated in cancer. A, Schematic representation of the characterized cancer-associated lincRNAs. Genes disturbed directly by 
carcinogens are genetic mediators of cancer and at the top layer of the cancer network (black nodes). Genes acting as hubs in the cancer network are key 
regulators (purple nodes). Rounded nodes denote coding genes; elliptic nodes denote long ncRNA genes. B, GO enrichment analysis revealed 97 coding 
genes as genetic mediators in cancer. C, LincRNA Scrip_2379 subnetwork. This subnetwork consists of Scrip_2379 (center) and its 51 direct neighbors. 
Genes colored in pink are known to play a role in the cell cycle and signaling pathways. Genes colored in green are involved in the regulation of cellular 
process. Yellow denotes other functions. Edges colored in light grey (or green) are negative (or positive) correlations. D, Schematic representation of the 
characterized key regulators in cancer. It is hypothesized that if a central gene has a close relationship with its gene set, which is associated with cancer, this 
central gene could be associated with cancer via the function of the gene set. 
as lung cancer-related genes (P<1016). Among the three 
lincRNA genetic mediators, the functions of Scrip_2379 
(Figure 2C) and Scrip_2616’ were annotated as cell cycle 
regulation. Overall, using the reverse-engineered coding-     
noncoding gene regulatory network, we identified three 
lincRNAs located in the top layer of the regulatory network 
and which acted as genetic mediators with important roles 
in cancer. 
Next, we characterized lincRNAs acting as key regula-
tors in tumorigenesis and their putative mechanisms impli-
cated in cancer. We presumed that if a gene was closely 
related to a gene set associated with cancer, the gene may be 
associated with cancer (Figure 2D). We found that the func-
tional similarity of the central gene and its directly co-      
expressed genes was high (the ratio might reach 50%) when 
the number of its co-expressed genes was >20. Therefore, 
we considered that such a central gene and its directly 
co-expressed gene set had a close relationship. Then, we 
investigated the linkage between gene sets and cancer by 
drawing a cancer map based on the gene sets (we named 
this the cancer gene set map, CGSM), which could deter-
mine whether the sets were induced or repressed in a sig-
nificant fraction of the microarrays with cancer condition 
[36]. In the co-expressed network, 73 lincRNAs-related 
gene sets were obtained and 500 coding gene-related gene 
sets were randomly selected. Then, we measured the rela-
tionships between these gene sets and cancer through 546 
microarray expression profiles involving four cancer types 
and corresponding normal samples (Figure 3A). Several 
gene sets had similar functions and were combined into the 
same cluster. By CGSM analysis of 500 coding gene-related 
gene sets, we found that clusters related to immune and the 
inflammatory response were repressed in lung tumors, while 
those related to the cell cycle were induced across several 
cancer types (Figure 3A). The results were consistent with 
the hypothesis that tumors were caused by aberrations in the 
regulation of key immune system and survival pathways. In 
the results, 167 coding gene-centered gene sets were differ-
ently expressed in lung cancer and many of these were 
genes annotated with the cell cycle and immune system 
processes (Figure S5A). Thus, these central genes were re-
garded as putative lung cancer-related genes. Comparing 
these with the 2897 lung cancer-related genes we collected, 
we found that a significant portion (79/167) were the same 
(P<1016). For example, the KIF11-related gene set, in 
which 56 of 80 genes were involved in the cell cycle pro- 
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Figure 3  The cancer gene set map (CGSM). A, The CGSM of coding gene-centered gene sets. The rows indicate the state of each gene set and the columns 
indicate experiment sets. The red (or green) entry indicates that the experiment sets in which the corresponding gene set was significantly induced (or re-
pressed) contained more arrays enriched for the given gene set than would be expected by chance. The rows were clustered into distinct clusters, and the 
resulting clusters are indicated by horizontal lines. We manually assigned a concise label to each cluster (right; colored bars). B, The CGSM of lincRNA 
gene-centered gene sets. The stars denote sets detected in both experiments. 
cess, could be induced in several cancer types (Figure S5B). 
Previous reports have shown that KIF11, acting as an at-
tractive anticancer target and playing a key role during cell 
mitosis, is associated with several types of tumors such as 
non-small cell lung cancer, glioblastomas, and breast cancer 
[37]. These results suggested that we can identify new can-
cer-related genes through exploring the relationships be-
tween gene-related gene sets and cancer.  
We then used this approach to explore cancer-related 
lincRNAs. First, the expression of 73 lincRNA-centered 
gene sets (lincRNA-sets) across various conditions was de-
tected; among these, some were induced or repressed in 
cancer (Figure 3B). For example, there were 12 lincRNA-sets 
dysregulated in lung cancer relative to normal lung, and 
four of them were detected in both experiments (Figure 3B, 
Table S5). We proposed that the 12 central lincRNAs may 
be associated with lung cancer. As an example, the 
Scrip_2379-related gene set, including 51 coding genes the 
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functions of which were annotated as negative regulators of 
cell death or apoptosis and positive regulators of the cell 
cycle, was significantly up-regulated in lung cancer (P<      
108). It is noteworthy that Scrip_2379 also acted as a  
genetic mediator in lung cancer (Figure 2C). We thus pre-
sumed that this lincRNA may have an impact on lung can-
cer through the cell cycle process. As another example, the 
Scrip_2185-related set, including 20 coding genes the func-
tions of which were annotated as immune and T cell activa-
tion-related functions, was significantly down-regulated in 
lung cancer (P<1010) (Figure S6A). Interestingly, the ge-
nomic location of lincRNA Scrip_2185 overlapped with 
several T cell receptor beta chain-related noncoding genes 
(Figure S6B). These results suggested that the metabolic 
disturbance and signal pathway dysregulation, both of 
which had been validated as the cause of cancer, may also 
be associated with lincRNAs (Table S5). Therefore, lin-
cRNAs may be used for cancer diagnosis and prognosis, 
and as potential therapeutic targets. 
3  Discussion  
LincRNAs were first discovered by large-scale sequencing 
of full-length cDNA libraries in mouse and expression pro-
filing using high-resolution genome tiling arrays [38]. 
RNA-Seq has allowed the analysis of mammalian tran-
scriptomes with an unprecedented resolution and opened the 
way to studying lincRNAs in mammalian cells [39]. Nu-
merous methods have been established based on RNA-Seq 
[40–43]. However, most of them depend on existing gene 
annotations, and thus they have been limited to the discov-
ery of new lincRNAs and their complete structures. There-
fore, we applied an alternative method, Scripture, which 
uses an ab initio reconstruction approach to identify the 
complete transcriptome of an individual sample solely from 
the unannotated genome sequence and RNA-Seq reads [16]. 
Multiple studies have shown that significant numbers of 
lincRNAs exhibit cell type-specific expression [9] and lo-
calize to specific subcellular compartments. The catalog of 
human lincRNAs genes is certain to be incomplete, because 
it is based on RNA-Seq reads of only six cell types. Using a 
completely different method, Khalil et al. [15] recently 
identified ~3300 human lincRNAs by analyzing the chro-
matin-state maps of six human cell types. However, the 
structures of most of these genes are not available. To relia-
bly expand our catalog of human lincRNAs as much as pos-
sible, we extracted ESTs located in lincRNA regions and 
used the findpeaks method to construct thousands of puta-
tive lincRNA transcripts. Then, we only focused on inter-
genic lincRNAs while other kinds of ncRNAs, such as anti-
sense transcripts, promoter-associated transcripts, 3′ UTR-     
associated transcripts and intronic transcripts of protein 
coding genes, were removed to avoid the extension of or 
transcriptional noise from protein-coding transcripts [44]. 
The median distance of lincRNA to neighboring pro-
tein-coding gene was >100 kb further indicating that their 
transcriptions were independent. Finally, after applying a 
series of filters, we obtained >3000 lincRNAs, most of 
which had transcriptional signatures and higher evolution-
ary conservation relative to introns. In fact, although two 
different methods and large data sets were used to identify 
lincRNAs, the real repertoire of these transcripts in human 
cells contains many more transcripts than those cataloged in 
this study.  
For large-scale functional annotation of these lincRNAs, 
we applied a previously established workflow [22]. The 
workflow included two major steps: re-annotation of the 
Human Genome U133 Plus 2.0 Array and construction of a 
“two color” co-expression network. Unlike previous work, 
which predicted the functions of lincRNAs using three 
methods, we did not apply a method based on genomic 
co-location and only used a hub-based and module-based 
method in this study, because the median distance of lin-
cRNAs to their corresponding neighboring protein-coding 
gene was large (>100 kb). The results obtained from the two 
functional prediction methods were coherent and comple-
mentary, strengthening the validity of the predictions. 
It is difficult to characterizing the association between 
lincRNA and cancer by experiments owing to the complexity 
and scarcity of information on lincRNAs. A few studies 
have shown that some lincRNAs, such as HOTAIR, lin-
cRNA-p21 or MALAT-1, acting as “tumor-suppressor 
ncRNAs” or “oncogenic ncRNAs”, have a major role in the 
development of cancer [21,23,45]. For example, lincRNA-        
p21 could be located within the promoters of p53-regulated 
genes through a physical association with hnRNP-K to me-
diate gene expression in a p53-mediated apoptosis pathway, 
and was considered as a repressor in p53-dependent tran-
scriptional responses [21]. This study implied that lin-
cRNAs may serve as tumor suppressor genes or oncogenes 
to play important roles in cancer, and that they may be used 
as potential targets for the development of cancer therapies 
in the future.  
Cancer is an extremely complex disease mainly caused 
by the mutational alteration of numerous genes including 
both coding and noncoding genes that control critical cellu-
lar pathways. Thus, a deep understanding of cancer will 
require a comprehensive characterization of the genes that 
are dysregulated in tumors, which cannot be achieved solely 
by experiment. The most common method for large-scale 
identification of tumor-associated genes is comparing the 
expression profiles of tumor with those of normal samples. 
However, there are usually hundreds to thousands of genes 
that exhibit expression changes in cancer relative to normal 
samples. Thus, it is important to determine the genes acting 
as principal players in tumorigenesis. To address this prob-
lem, we proposed a genetic mediator and key regulator 
model, which can determine the genes including both pro-
tein coding genes and lincRNAs that are directly affected by 
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cancer or which play key roles in tumorigenesis. To identify 
genetic mediators of cancer, Collins et al. developed a 
method and applied it to non-recurrent primary and meta-
static prostate cancer data [33,34]. In the present study, we 
identified three lincRNAs as genetic mediators in lung can-
cer using this method. Our results also show that dysregula-
tion of several important signaling pathways such as cell 
proliferation, cell death and the cell cycle is involved in 
lung cancer. It is noteworthy that except for genetic media-
tors at the top layer of gene regulatory network, a few genes 
such as hubs relating with many other genes also play key 
roles during cancer development. On this point, we used 
lincRNA-centered subnetworks parsed from our co-expre-       
ssion network as central lincRNA-related gene sets. We 
proposed that if gene expression of the gene sets changed 
significantly in cancer, the central gene could associate with 
cancer. Based on the expression of central genes and their 
gene sets, we drew a cancer map showing whether the sets 
were induced or repressed in cancer [36]. According to this 
analysis, we identified 12 lincRNA-gene sets that were 
dysregulated in lung cancer; therefore, the central genes 
may be core regulators in tumorigenesis.  
Our study is the first attempt using combinational methods 
to systematically analyze human lincRNAs, offering a new 
approach to characterizing cancer-associated lincRNAs by 
bioinformatics. The results of our work will pave the way 
for computational analysis of lincRNAs and will be a valuable 
resource for further biological research. Just as miRNAs act 
as critical gene regulators in cells and as effective targets in 
cancer therapeutics, the majority of lincRNAs we identified 
also have various functions in cellular networks and may 
provide new approaches to the diagnosis and treatment of 
cancer. Nevertheless, the findings described in this article 
are merely a starting point for the study of lincRNAs, and 
much effort should be put into unveiling the mystery of 
lincRNAs. 
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